TCL Archive New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept. February 28, 1975
TCL Archive Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision December 2, 2011
TCL Archive Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49 April 4, 1997
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted March 19, 1976